Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort

[1]  A. Ogdie,et al.  2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative , 2015, Annals of the rheumatic diseases.

[2]  L. Criswell,et al.  Genetic contribution of DKK-1 polymorphisms to RA structural severity and DKK-1 level of expression , 2015, Annals of the rheumatic diseases.

[3]  Cesar Libanati,et al.  Romosozumab in postmenopausal women with low bone mineral density , 2014, The New England journal of medicine.

[4]  X. Mariette,et al.  First‐Year Radiographic Progression as a Predictor of Further Progression in Early Arthritis: Results of a Large National French Cohort , 2013, Arthritis care & research.

[5]  A. Abbas,et al.  Serum Dickkopf-1 Level in Postmenopausal Females: Correlation with Bone Mineral Density and Serum Biochemical Markers , 2013, Journal of osteoporosis.

[6]  M. Stolina,et al.  Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis , 2013, Annals of the rheumatic diseases.

[7]  R. Orlowski,et al.  p38 MAPK in myeloma cells regulates osteoclast and osteoblast activity and induces bone destruction. , 2012, Cancer research.

[8]  F. Guillemin,et al.  Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort , 2012, Arthritis Research & Therapy.

[9]  A. Zhernakova,et al.  Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis , 2012, Annals of the rheumatic diseases.

[10]  X. Mariette,et al.  Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort , 2012, Annals of the rheumatic diseases.

[11]  Y. Goekoop-Ruiterman,et al.  Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-up , 2012, Annals of the rheumatic diseases.

[12]  J. Zwerina,et al.  High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis , 2011, Annals of the rheumatic diseases.

[13]  A. Rouzi,et al.  Determinants of serum sclerostin in healthy pre‐ and postmenopausal women , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  P. Sfikakis,et al.  Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis. , 2011, Clinical and experimental rheumatology.

[15]  L. Melton,et al.  Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  J. Shaughnessy,et al.  The role of Dickkopf-1 in bone development, homeostasis, and disease. , 2009, Blood.

[17]  Mark L. Johnson,et al.  Osteocytes, mechanosensing and Wnt signaling. , 2008, Bone.

[18]  M. Dougados,et al.  The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. , 2007, Joint, bone, spine : revue du rhumatisme.

[19]  Georg Schett,et al.  Dickkopf-1 is a master regulator of joint remodeling , 2007, Nature Medicine.

[20]  R. Baron,et al.  Deletion of a Single Allele of the Dkk1 Gene Leads to an Increase in Bone Formation and Bone Mass , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  D. Heinegård,et al.  Prognostic laboratory markers of joint damage in rheumatoid arthritis , 2004, Annals of the rheumatic diseases.

[22]  F. Zhan,et al.  The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. , 2003, The New England journal of medicine.

[23]  John A Latham,et al.  Osteocyte control of bone formation via sclerostin, a novel BMP antagonist , 2003, The EMBO journal.

[24]  T. Saxne,et al.  Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis , 2003, Annals of the rheumatic diseases.

[25]  J. Vencovský,et al.  Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis , 2003, Annals of the rheumatic diseases.

[26]  D. Galas,et al.  A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population. , 2002, American journal of medical genetics.

[27]  J. I. Izpisúa Belmonte,et al.  Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. , 2001, Developmental cell.

[28]  M. Dougados,et al.  Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. , 2001, Arthritis and rheumatism.

[29]  M Dioszegi,et al.  Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). , 2001, Human molecular genetics.

[30]  D. Galas,et al.  Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. , 2001, American journal of human genetics.

[31]  P. Jones,et al.  Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study. , 1998, The Journal of rheumatology.

[32]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[33]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[34]  E. Solomou,et al.  Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. , 2010, Arthritis and rheumatism.

[35]  A. Silman,et al.  Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .

[36]  M. V. van Leeuwen,et al.  Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). , 1995, The Journal of rheumatology.

[37]  M. Prevoo,et al.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.

[38]  H. Holman,et al.  Measurement of patient outcome in arthritis. , 1980, Arthritis and rheumatism.